A powerful federal advisory panel that shapes how vaccines are used across the United States has begun reconsidering decades-old immunization recommendations, a move that public health experts say could have far-reaching consequences for vaccine access, insurance coverage and public trust.
The Advisory Committee on Immunization Practices, or ACIP, advises the Centers for Disease Control and Prevention on which vaccines should be routinely recommended for children and adults. Those recommendations are widely followed by doctors, insurers and state governments and often determine which vaccines are covered at no cost under federal health law.
In recent meetings, the panel has signaled it will review all existing vaccine recommendations, including long-established guidance for childhood immunizations such as hepatitis B, measles, polio and influenza, according to reporting by The Guardian and other outlets.
The shift follows a sweeping overhaul of ACIP’s membership in 2025, when the Department of Health and Human Services replaced the panel’s previous members with new appointees selected under Health Secretary Robert F. Kennedy Jr. Kennedy has been a prominent critic of vaccine safety in the past, though he has said he supports vaccines that are proven safe and effective.
Public health officials and medical groups say the panel’s new direction marks a sharp break from decades of science-based consensus.
“This is unprecedented,” said one former CDC adviser, who warned that reopening settled vaccine guidance could confuse patients and clinicians and weaken confidence in immunization programs.
ACIP recommendations play a central role in determining which vaccines are included on the CDC’s official immunization schedules. Those schedules, in turn, influence insurance coverage requirements, including which vaccines must be covered without copays under the Affordable Care Act.
Some of the changes under discussion include reassessing the routine hepatitis B vaccine given to newborns, revisiting guidance for COVID-19 and influenza vaccines, and reconsidering how certain childhood vaccines are recommended across age groups, according to reports from health policy analysts and medical journals.
Medical organizations have reacted with concern. The American Academy of Pediatrics recently released its own childhood immunization schedule, reaffirming support for routine vaccinations and signaling a growing split between federal guidance and professional medical groups.
Health experts warn that scaling back routine recommendations could lead to lower vaccination rates, particularly among children, and increase the risk of outbreaks of preventable diseases such as measles and polio.
“Recommendations matter,” said Dr. Georges Benjamin, executive director of the American Public Health Association. “When guidance becomes optional or unclear, vaccination rates tend to fall.”
The debate comes at a time when the U.S. has already seen a resurgence of measles cases in recent years, driven largely by declining vaccination coverage in some communities.
Supporters of the review process argue that reexamining guidance could increase transparency and public confidence, particularly among Americans who distrust federal health agencies. Critics counter that reopening settled science without new evidence risks politicizing public health.
The CDC has said it will continue to evaluate ACIP’s recommendations before adopting them as official agency policy. Any changes approved by the CDC would be reflected in updated immunization schedules later this year.
ACIP is expected to continue its review during upcoming public meetings, with additional votes anticipated in the coming months.
